An early-phase clinical trial of an experimental vaccine that targets cancer stem cells in patients with recurrent glioblastoma multiforme, the most common and aggressive malignant brain tumor, has been launched.
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/g...
Fuente : http://feeds.sciencedaily.com/~r/sciencedaily/~3/g...